Open AccessRandomized phase II trial reporting overall survival advantage by adding local consolidative therapy to systemic therapy for oligometastatic non-small cell lung cancer: another step forward on the long road of evidence-based medicine for oligometastatic disease
Author(s) -
Paul Windisch,
Matthias Gückenberger
Publication year - 2019
Publication title -
journal of thoracic disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.682
H-Index - 60
eISSN - 2077-6624
pISSN - 2072-1439
DOI - 10.21037/jtd.2019.08.123
Subject(s) - medicine , randomized controlled trial , systemic therapy , lung cancer , oncology , radiation therapy , medical physics , intensive care medicine , cancer , breast cancer